These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18795266)

  • 21. The AMPA receptor potentiator Org 26576 modulates stress-induced transcription of BDNF isoforms in rat hippocampus.
    Fumagalli F; Calabrese F; Luoni A; Shahid M; Racagni G; Riva MA
    Pharmacol Res; 2012 Feb; 65(2):176-81. PubMed ID: 22079295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition.
    Galici R; Boggs JD; Aluisio L; Fraser IC; Bonaventure P; Lord B; Lovenberg TW
    Neuropharmacology; 2009 Jun; 56(8):1131-7. PubMed ID: 19345233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.
    Connor DA; Gould TJ
    Neuropharmacology; 2017 Oct; 125():272-283. PubMed ID: 28778833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M
    Grannan MD; Mielnik CA; Moran SP; Gould RW; Ball J; Lu Z; Bubser M; Ramsey AJ; Abe M; Cho HP; Nance KD; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW; Jones CK
    ACS Chem Neurosci; 2016 Dec; 7(12):1706-1716. PubMed ID: 27617634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar-Kyoto rats.
    Papp M; Gruca P; Lason M; Litwa E; Solecki W; Willner P
    J Psychopharmacol; 2020 Dec; 34(12):1418-1430. PubMed ID: 33200659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF.
    Gourley SL; Kedves AT; Olausson P; Taylor JR
    Neuropsychopharmacology; 2009 Feb; 34(3):707-16. PubMed ID: 18719621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
    Lockhart B; Iop F; Closier M; Lestage P
    Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.
    Li Z; Bonhaus DW; Huang M; Prus AJ; Dai J; Meltzer HY
    Eur J Pharmacol; 2007 Oct; 572(2-3):129-37. PubMed ID: 17628522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
    Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ampakine CX546 bolsters energetic response of astrocytes: a novel target for cognitive-enhancing drugs acting as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators.
    Pellerin L; Magistretti PJ
    J Neurochem; 2005 Feb; 92(3):668-77. PubMed ID: 15659236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
    Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
    Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex.
    Di Liberto V; Frinchi M; Verdi V; Vitale A; Plescia F; Cannizzaro C; Massenti MF; Belluardo N; Mudò G
    Psychopharmacology (Berl); 2017 Feb; 234(4):559-573. PubMed ID: 27957715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.
    Ladurelle N; Gabriel C; Viggiano A; Mocaër E; Baulieu EE; Bianchi M
    Psychopharmacology (Berl); 2012 Jun; 221(3):493-509. PubMed ID: 22160164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques.
    Malkova L; Kozikowski AP; Gale K
    Neuropharmacology; 2011 Jun; 60(7-8):1262-8. PubMed ID: 21185313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats.
    Yabuki Y; Shioda N; Maeda T; Hiraide S; Togashi H; Fukunaga K
    Brain Res; 2014 Apr; 1557():90-100. PubMed ID: 24561222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M
    Mandai T; Kasahara M; Kurimoto E; Tanaka M; Suzuki M; Nakatani A; Kimura H
    Neuroscience; 2019 Aug; 414():60-76. PubMed ID: 31299348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMPA receptor potentiators for the treatment of CNS disorders.
    O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
    Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in rats.
    Poddar I; Callahan PM; Hernandez CM; Pillai A; Yang X; Bartlett MG; Terry AV
    Pharmacol Biochem Behav; 2020 Feb; 189():172853. PubMed ID: 31945381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The memory-enhancing effects of 7,8,4'-trihydroxyisoflavone, a major metabolite of daidzein, are associated with activation of the cholinergic system and BDNF signaling pathway in mice.
    Ko YH; Kwon SH; Ma SX; Seo JY; Lee BR; Kim K; Kim SY; Lee SY; Jang CG
    Brain Res Bull; 2018 Sep; 142():197-206. PubMed ID: 30031818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.